
Results
2168
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2168 companies
NurExone Biologic
Market Cap: CA$59.8m
A pharmaceutical technology company, develops a platform for biologically guided exosome-based therapies for the treatment of central nervous system injuries.
NRX
CA$0.59
7D
24.2%
1Y
-26.3%
Medical Developments International
Market Cap: AU$60.3m
Provides emergency medical solutions in Australia, Europe, the United States, and internationally.
MVP
AU$0.54
7D
9.2%
1Y
-15.7%
DocGo
Market Cap: US$43.0m
Operates as a mobile healthcare services company in the United States and the United Kingdom.
DCGO
US$0.38
7D
-46.3%
1Y
-76.7%
Incannex Healthcare
Market Cap: US$42.7m
A clinical-stage biopharmaceutical company, engages in the research and development of psychedelic medicines and therapies for patients with chronic diseases in Australia.
IXHL
US$3.62
7D
9.2%
1Y
-83.7%
Edesa Biotech
Market Cap: US$42.7m
A clinical-stage biopharmaceutical company, engages in the research and development, manufacture, and commercialization of pharmaceutical products for inflammatory and immune-related diseases.
EDSA
US$4.40
7D
-22.1%
1Y
81.8%
QT Imaging Holdings
Market Cap: US$42.6m
Engages in the research, development, and commercialization of body imaging systems with low frequency sound waves for detection, diagnosis, and treatment of diseases in the United States and Internationally.
QTI
US$3.31
7D
22.6%
1Y
-52.6%
Werewolf Therapeutics
Market Cap: US$42.5m
A biopharmaceutical company, engages in the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer and other immune-mediated conditions.
HOWL
US$0.88
7D
117.8%
1Y
-35.5%
Neurothera Labs
Market Cap: CA$58.5m
Engages in the development of a portfolio of drugs based on cannabinoid molecules.
NTLX
CA$0.34
7D
-1.4%
1Y
n/a
Interpace Biosciences
Market Cap: US$42.2m
Provides molecular diagnostic tests and pathology services for evaluating cancer risk in the United States.
IDXG
US$1.43
7D
-15.9%
1Y
68.2%
China Pharma Holdings
Market Cap: US$42.2m
Develops, manufactures, and markets pharmaceutical products for human use in the People’s Republic of China.
CPHI
US$0.95
7D
-12.0%
1Y
-33.1%
Elutia
Market Cap: US$42.1m
A commercial-stage company, focuses on developing drug-eluting biomatrix products for use in surgical reconstruction and related applications.
ELUT
US$0.95
7D
-2.1%
1Y
-60.0%
Milestone Scientific
Market Cap: US$42.0m
A biomedical technology company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical and dental use in the United States, China, and internationally.
MLSS
US$0.47
7D
-3.1%
1Y
-19.3%
InspireMD
Market Cap: US$41.8m
A medical device company, focuses on the development and commercialization of products for the treatment of carotid artery disease and other vascular conditions in the United States, Germany, Italy, Russia, Poland, and internationally.
NSPR
US$0.87
7D
-1.1%
1Y
-63.8%
Aligos Therapeutics
Market Cap: US$41.7m
A clinical-stage biopharmaceutical company, focuses on the development of novel therapeutics to address unmet medical needs in liver and viral diseases.
ALGS
US$6.93
7D
5.4%
1Y
-32.1%
Little Green Pharma
Market Cap: AU$58.0m
Produces and sells cannabis-based medicinal products across Australia and Europe.
LGP
AU$0.07
7D
-5.4%
1Y
-46.2%
MedPal AI
Market Cap: UK£30.3m
Operates as a digital health and artificial intelligence company focused on wellness management in United Kingdom.
MPAL
UK£0.037
7D
-2.6%
1Y
-42.3%
Botanix Pharmaceuticals
Market Cap: AU$57.4m
Operates as a commercial dermatology company in Australia and the United States.
BOT
AU$0.021
7D
5.0%
1Y
-86.9%
GoldCoast Resource
Market Cap: CA$56.5m
Engages in the exploration of gold deposits in Ghana.
GCR
CA$0.80
7D
-5.9%
1Y
-30.3%
Ceretas
Market Cap: AU$57.1m
Engages in developing a portable and non-invasive therapeutic ultrasound platform for the treatment of Alzheimer's disease and other neurodegenerative conditions in Australia.
CTS
AU$0.80
7D
8.1%
1Y
n/a
Singular Health Group
Market Cap: AU$57.0m
A medical technology company, engages in the development and provision of 3DiCom software medical technology in Australia.
SHG
AU$0.18
7D
2.9%
1Y
-43.8%
SANUWAVE Health
Market Cap: US$40.6m
Operates as a medical device company in the United States and internationally.
SNWV
US$4.72
7D
-4.8%
1Y
-88.9%
Scilex Holding
Market Cap: US$40.3m
Focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain.
SCLX
US$5.66
7D
-11.6%
1Y
-69.1%
CervoMed
Market Cap: US$39.6m
A clinical-stage biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders.
CRVO
US$2.63
7D
0.8%
1Y
-72.1%
EUDA Health Holdings
Market Cap: US$39.6m
Engages in the provision of non-invasive healthcare services primarily in Singapore, Malaysia, and China.
EUDA
US$15.40
7D
6.3%
1Y
-71.2%
Theralase Technologies
Market Cap: CA$54.7m
A clinical stage pharmaceutical company, engages in the research, development, and commercialization of energy activated small molecules and associated drug formulations in Canada, the United States, and internationally.
TLT
CA$0.19
7D
2.7%
1Y
-5.0%
Cell Source
Market Cap: US$39.5m
A biotechnology company, engages in developing cell therapy treatments based on the management of immune tolerance.
CLCS
US$0.65
7D
0%
1Y
58.0%
Ocumetics Technology
Market Cap: CA$54.4m
Engages in research, development, production, and sale of vision enhancement products in Canada.
OTC
CA$0.41
7D
-3.5%
1Y
-69.9%
Growth Stalk Holdings
Market Cap: US$39.2m
Engages in the sowing of the seeds for cultivation and selling of cannabis.
GSTK
US$1.22
7D
0%
1Y
n/a
Compumedics
Market Cap: AU$52.9m
Engages in the research, development, manufacture, and distribution of medical equipment and related technologies in the Americas, Australia, the Asia Pacific, Europe, and the Middle East.
CMP
AU$0.27
7D
17.8%
1Y
-7.0%
VIP Gloves
Market Cap: AU$55.1m
Engages in the production and trading of nitrile gloves in Malaysia.
VIP
AU$0.07
7D
0%
1Y
n/a
Cryo-Cell International
Market Cap: US$36.8m
Engages in cord blood and cord tissue cryopreservation services in the United States.
CCEL
US$4.39
7D
18.6%
1Y
1.2%
PAVmed
Market Cap: US$36.2m
Engages in acquiring, developing, and commercializing novel products that target unmet needs in the United States.
PAVM
US$5.10
7D
-4.2%
1Y
-65.2%
BetterLife Pharma
Market Cap: US$36.0m
A biotechnology company, engages in the development of psychedelic-derived compounds.
BETR.F
US$0.22
7D
8.2%
1Y
248.5%
OneMedNet
Market Cap: US$35.6m
A healthcare software company, provides digital medical image management, exchange, and sharing solutions in the Americas, Europe, and the Middle East.
ONMD
US$0.59
7D
-3.3%
1Y
-22.7%
MedMira
Market Cap: CA$49.1m
A biotechnology company, researches, develops, manufactures, and sells rapid diagnostics and technology platforms in North America, Europe, and internationally.
MIR
CA$0.065
7D
8.3%
1Y
-13.3%
Radnostix
Market Cap: US$35.3m
Manufactures and sells nuclear medicine calibration and reference standards, cobalt-60 products, sodium iodide I-131 drug product, and radiochemicals for clinical research and life sciences in the United States and internationally.
INIS
US$0.059
7D
-12.6%
1Y
-36.2%